🆕📰.A big shoutout to @drgautammehta @RajivJalan1 & @CyberLiver for this groundbreaking tech- #AlcoChange that encourages patients with alcohol-related liver disease to stay #sober through behaviour change 👏.#livertwitter #alcohol #liver #soberlife.

This week is #AlcoholAwarenessWeek with a theme of 'Understanding #AlcoholHarm.It’s a chance to think about drinking and understand alcohol harm and the centre-stage role that it plays in our lives and raise awareness among our friends and family. @helloDryDays @CyberLiver @NHSuk

By 2030, liver disease is expected to become one of the top three health concerns in the UK, a challenge intensified by the shortfall in specialist care. On #WorldLiverDay we aim to address these challenges through our #DigitalMedicineDevice platform. @DHealthLDN thank you😊.

On this #WorldLiverDay we are excited touch the lives of 175 patients in our real-world trial for @alcochange. Thanks to our partners in joining our fight against #AlcoholHarm @NIHRresearch @SouthamptonCTU @NHSuk @ucl @CyberLiver @drgautammehta @RajivJalan1

Alcohol-associated liver disease (ArLD), is a major cause of liver disease in Europe, highlighting the need for effective public health measures. #AlcoChange is a #DigitalMedicineDevice that will help stop or cut down your alcohol use. #WorldLiverDay #Stepupforliverhealth #Liver

RT @CyberLiver: 1.5 billion people live with chronic liver disease, and 2 million lives are lost yearly. Early prevention can save many of….

Great to meet & catch-up with our @AlcoChangeStudy Trail Manager 👱🏼‍♀️Liz Dixon & discuss strategies to boost recruitment in the next few weeks and take the benefit of #alcochange to more people to reduce #AlcoholHarm. @SouthamptonCTU @UHSFT @drgautammehta @DHSCgovuk #livertwitter

A very engaging and insightful session about alcohol consumption trends and harm since the pandemic. It's worrying and sad. 😪 Digital interventions like @helloDryDays by AlcoChange are aiming to help reduce that harm and burden. #MACPconf #alcoholharm @rcgp @VictimOfMaths

RT @CyberLiver: 🙏 What a day of learning and discussion! Amazing people at our desk. #BASL2023 #BASL @BASLedu @basl_events #digitalmedicine….

RT @CyberLiver: 🏁 That's a wrap 🙏What an incredible conference it's been! Lots of learning and connections 👫 #BASL2023 #BASL #CyberLiver #L….

RT @CyberLiver:

RT @CyberLiver:

RT @rkumar: Diversity and inclusion research is very important to ensure that liver services are accessible to everyone who needs it #BASL2….

RT @CyberLiver: 🚨 𝔻𝕚𝕧𝕖𝕣𝕤𝕚𝕥𝕪 𝕒𝕟𝕕 𝕚𝕟𝕔𝕝𝕦𝕤𝕚𝕠𝕟 𝕚𝕟 𝕡𝕒𝕥𝕚𝕖𝕟𝕥 𝕔𝕒𝕣𝕖 𝕒𝕣𝕖 𝕦𝕡 𝕗𝕠𝕣 𝕕𝕚𝕤𝕔𝕦𝕤𝕤𝕚𝕠𝕟 𝕟𝕖𝕩𝕥. How can technology assist? Ask our experts to know mo….

RT @CyberLiver: 🌟Day 2 of #BASL2023 is underway! We're excited for today's discussions on Personalising Liver Care. Drop in for a quick dem….

RT @CyberLiver: Pleasure to meet @DrADhanda at our booth and demonstrating CirrhoCare at #BASL2023 #BASL. Great conversation and lots of qu….

RT @CyberLiver: 🍴 Lunch Time: Perfect opportunity to visit our booth at Durham Hall for a demo. Learn more about our solutions and how they….

RT @KGananandan: Following the @CirrhoCare study, we demonstrate that fat mass could be an important digital nutritional biomarker in decom….

Great team at @GSTTnhs! We are equally excited 😊 #AlcoChange #livertwitter #liverhealth #clinicaltrials.

Thanks to Louise, @OUHospitals and @NIHRCRN_tvsm for raising awareness of the #AlcoChange study. Find out more about the study 👉 #AlcoholAwareness #AlcoholAwarenessWeek #ClinicalTrials .#livertwitter @RajivJalan1 @drgautammehta @SouthamptonCTU.